Urology Devices Market Size to grow by USD 16204.4 million between 2024-2028
According to a research report “ Urology Devices Market” by Application (Kidney failure treatment devices, UI management devices, BPH treatment devices, Urolithiasis treatment devices, Other) End-user (Hospitals and ASCs, Dialysis centers, Homecare and clinics) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 16204.4 million, at a CAGR of 6.78% during the forecast period. The global burden of chronic kidney disease (CKD) is a significant challenge, with an estimated 850 million individuals affected, including one in ten adults. This non-communicable disease is projected to become the fifth leading cause of years of life lost globally by 2040. As CKD progresses, it can lead to end-stage renal disease (ESRD), requiring renal replacement therapy (RRT) for approximately 2 million patients worldwide. In the US alone, the CDC reports that 37 million adults, or 15% of the population, are affected by CKD. The increasing prevalence of CKD presents a substantial business opportunity for urology devices market, as these devices play a crucial role in the diagnosis, treatment, and management of this debilitating condition..
Browse market data tables, figures, and in-depth TOC on “Urology Devices Market” by Application (Kidney failure treatment devices, UI management devices, BPH treatment devices, Urolithiasis treatment devices, Other) End-user (Hospitals and ASCs, Dialysis centers, Homecare and clinics) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Application, the Kidney failure treatment devices segment is projected to dominate the market size in 2024
In the Urology Devices Market, renal dialysis plays a significant role in addressing kidney failure or end-stage renal disease (ESRD) caused by chronic kidney disease (CKD). This process artificially filters blood, eliminating excess wastes such as drugs, urea, uric acid, and creatinine. Dialysis facilitates the diffusion of solute molecules through a semipermeable membrane, preventing larger molecules like colloidal plasma proteins and protoplasm from passing. The kidney failure treatment segment encompasses hemodialysis devices, peritoneal dialysis devices, and dialysis catheters. Among these, hemodialysis is the most commonly used dialysis method.
By End-user, Hospitals and ASCs segment is expected to hold the largest market size for the year 2024
The hospital and ambulatory surgery centers (ASCs) segment is a significant market for urology devices. Hospitals serve as primary end-users, utilizing specialized equipment for intricate urology procedures such as ureteroscopy. Given the complexity of these surgeries and the necessity of skilled medical personnel, the majority of ureteroscopy procedures are executed in hospital settings. As leading healthcare providers, hospitals are well-equipped to manage complications and offer comprehensive care for urinary tract diseases.
North America is forecasted to hold the largest market size by region in 2024
The urology devices market represents a significant business opportunity, driven by the rising prevalence of urological disorders and advancements in medical technology. Key players in this sector invest in research and development to launch innovative products, catering to the growing demand for minimally invasive procedures and patient-centric solutions. This dynamic market is expected to witness robust growth in the coming years.
The Urology Devices Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Urology Devices Market encompasses a range of advanced technologies used in the diagnosis and treatment of various urological diseases. These include Minimally Invasive Surgery (MIS) robotic systems, such as those used for Robotic Surgery in urology, which facilitate precise and effective interventions for conditions like Bladder cancer, Kidney stones, and BPH (Benign Prostatic Hypertrophy). Key urology devices include Endoscopes, like Ureteroscopes and Cystoscopes, which enable endoscopic procedures for diagnosing and treating urological disorders. Consumables, such as insufflators, are essential for creating a sterile and controlled environment during surgeries. Urology robotic systems also play a significant role in Kidney transplants and managing End-stage renal diseases and Chronic kidney diseases through Dialysis. Urodynamic systems help assess Urinary incontinence and other functional disorders. The integration of Technology in urology devices has led to improved patient outcomes and enhanced efficiency in hospitals. In summary, the Urology Devices Market is a dynamic and evolving sector, driven by advancements in Technology and the growing need to address various Urological diseases and disorders.
Market Research Overview
The Urology Devices Market encompasses a range of technologies and instruments used in the diagnosis and treatment of various urological diseases. Key players in this market include Intuitive Surgical, Cardinal Health, Medtronic, Olympus, and Teleflex Incorporated. Products in this market include MIS robotic systems for procedures like robotic surgery for Benign Prostatic Hyperplasia (BPH), urological cancers, and urological surgeries. Other devices include insufflators for Minimally Invasive Surgery (MIS), endoscopes for Endoscopy procedures, and instruments for treating Urinary stones, Erectile dysfunction, Pelvic organ prolapse, and Urinary incontinence. Consumables such as single-use cystoscopes, ureteroscopes, and cystoscopes are also part of the market. Companies may face challenges with product recalls due to issues with kidney disorders, dialysis devices, and urological instruments. The market caters to hospitals, laboratories, and dialysis centers, addressing diseases like Urethral malignancies, Kidney diseases, and End-stage renal diseases. Urology robotic systems and urodynamic systems are essential tools in managing chronic kidney diseases and urological disorders.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
